Study of 11,000 tumors maps 134 DNA damage signatures across 16 cancers

byUniversity of ManchesterRelationship between SBS, DBS, ID, CN and SV signatures across cancers. Credit:Nature Genetics(2026). DOI: 10.1038/s41588-025-02474-xA team of cancer genomics scientists from

Updated on: April 09,2026

Study of 11,000 tumors maps 134 DNA damage signatures across 16 cancers

byUniversity of ManchesterRelationship between SBS, DBS, ID, CN and SV signatures across cancers. Credit:Nature Genetics(2026). DOI: 10.1038/s41588-025-02474-xA team of cancer genomics scientists from

Updated on:April 09,2026

Prostate cancer cells use unique metabolic pathway to thrive in bone tissue

by Elizabeth Chapin,University of KentuckyFong with members of his lab. Credit: University of KentuckyA University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their

Updated on: March 24,2026

Prostate cancer cells use unique metabolic pathway to thrive in bone tissue

by Elizabeth Chapin,University of KentuckyFong with members of his lab. Credit: University of KentuckyA University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their

Updated on:March 24,2026

RNA-based molecule enhances therapies against pancreatic cancer

byItalian Institute of TechnologyThe small ring-like structures visible in the magnified area represent the RAD51 protein, which has adopted a non-functional shape as a result of its interaction with

Updated on: March 27,2026

RNA-based molecule enhances therapies against pancreatic cancer

byItalian Institute of TechnologyThe small ring-like structures visible in the magnified area represent the RAD51 protein, which has adopted a non-functional shape as a result of its interaction with

Updated on:March 27,2026

Promising drug can inhibit aggressive breast cancer

by Erik Robinson,Oregon Health & Science UniversityGraphical abstract. Credit:Cell Reports Medicine(2025). DOI: 10.1016/j.xcrm.2025.102451New research reveals a drug developed by scientists at Ore

Updated on: March 23,2026

Promising drug can inhibit aggressive breast cancer

by Erik Robinson,Oregon Health & Science UniversityGraphical abstract. Credit:Cell Reports Medicine(2025). DOI: 10.1016/j.xcrm.2025.102451New research reveals a drug developed by scientists at Ore

Updated on:March 23,2026

Subtyping colorectal cancer may improve patient outcome predictions

byKyoto UniversityAn example usage of General Colorectal Cancer Signature (GCS). Credit: KyotoU / Makoto TaketoColorectal cancer, or CRC, is the world's second most lethal cancer based on the numb

Updated on: April 01,2026

Subtyping colorectal cancer may improve patient outcome predictions

byKyoto UniversityAn example usage of General Colorectal Cancer Signature (GCS). Credit: KyotoU / Makoto TaketoColorectal cancer, or CRC, is the world's second most lethal cancer based on the numb

Updated on:April 01,2026

Supportive cancer care: Most patients say human touch outshines tech

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew researchpublishedin the November 2025 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkexplores the percep

Updated on: April 02,2026

Supportive cancer care: Most patients say human touch outshines tech

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew researchpublishedin the November 2025 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkexplores the percep

Updated on:April 02,2026

Discovery of pancreatic tumor vulnerability could pave the way for new treatments

by Evelyne Dufresne,McGill UniversityCredit:Molecular Cancer(2026). DOI: 10.1186/s12943-026-02587-9A team from the Research Institute of the McGill University Health Center (The Institute), led by Jea

Updated on: June 05,2026

Discovery of pancreatic tumor vulnerability could pave the way for new treatments

by Evelyne Dufresne,McGill UniversityCredit:Molecular Cancer(2026). DOI: 10.1186/s12943-026-02587-9A team from the Research Institute of the McGill University Health Center (The Institute), led by Jea

Updated on:June 05,2026

Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer

by Associação Advanced Breast Cancer Global AllianceWhole body lean mass, which is an indicator of muscle mass, increased in the exercise group, while it decreased in the control group. Credit: Anne M

Updated on: April 01,2026

Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer

by Associação Advanced Breast Cancer Global AllianceWhole body lean mass, which is an indicator of muscle mass, increased in the exercise group, while it decreased in the control group. Credit: Anne M

Updated on:April 01,2026

New analytical method reveals how drug combinations act in leukemia

byTampere UniversityCoPISA workflow and possible states for target discovery in combinatorial therapy. Credit:Nature Communications(2026). DOI: 10.1038/s41467-026-70394-3Acute myeloid leukemia (AML) r

Updated on: May 15,2026

New analytical method reveals how drug combinations act in leukemia

byTampere UniversityCoPISA workflow and possible states for target discovery in combinatorial therapy. Credit:Nature Communications(2026). DOI: 10.1038/s41467-026-70394-3Acute myeloid leukemia (AML) r

Updated on:May 15,2026

PSMA therapy delays hormone therapy in prostate cancer, clinical trial finds

byRadboud UniversityNuclear medicine physician James Nagarajah from Radboudumc in the clinics. Credit: RadboudumcWhere previous research showed that PSMA therapy for prostate cancer can prolong the li

Updated on: May 25,2026

PSMA therapy delays hormone therapy in prostate cancer, clinical trial finds

byRadboud UniversityNuclear medicine physician James Nagarajah from Radboudumc in the clinics. Credit: RadboudumcWhere previous research showed that PSMA therapy for prostate cancer can prolong the li

Updated on:May 25,2026

Why some cancer therapies don't work for all patients: A tumor backup survival pathway

by Anne Trafton,Massachusetts Institute of TechnologyMany of the targeted tumors turn on a backup survival pathway that helps them keep growing when tyrosine kinase—pictured here as strands—is turned

Updated on: May 26,2026

Why some cancer therapies don't work for all patients: A tumor backup survival pathway

by Anne Trafton,Massachusetts Institute of TechnologyMany of the targeted tumors turn on a backup survival pathway that helps them keep growing when tyrosine kinase—pictured here as strands—is turned

Updated on:May 26,2026

Researchers demonstrate breakthroughs in cancer treatment quality through AI-enhanced data analytics

byUniversity of Tennessee at KnoxvilleSpatial clusters of the top six county-level features influencing LC mortality predictions using Getis-ord Gi. Credit:JCO Clinical Cancer Informatics(2025). DOI:

Updated on: March 29,2026

Researchers demonstrate breakthroughs in cancer treatment quality through AI-enhanced data analytics

byUniversity of Tennessee at KnoxvilleSpatial clusters of the top six county-level features influencing LC mortality predictions using Getis-ord Gi. Credit:JCO Clinical Cancer Informatics(2025). DOI:

Updated on:March 29,2026